The main risk is not whether POET’s technology matters; it is whether that relevance converts into durable, diversified, high-volume revenue before valuation patience runs out. The dominant gate is Malaysia production readiness, followed by conversion of the
Lumilens framework and other partner programs into accepted shipments. If POET proves repeat demand, the upside remains meaningful. If it stays stuck in milestone revenue and partner headlines, the stock is vulnerable because expectations are already rich.